Healthcare -
Biotechnology - NASDAQ - US
$ 3.91
0.256 %
$ 349 M
Market Cap
-8.89
P/E
TRVI - COST OF REVENUE
Cost of Revenue TRVI - Trevi Therapeutics, Inc.
123 K
LAST VALUE
56.84%
2 YEAR CAGR
39.84%
5 YEAR CAGR
0.00%
10 YEAR CAGR